News | April 11, 2026
Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
Subscribe To Our Newsletter & Stay Updated
